Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 5/2017

01-10-2017 | Correspondence

Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome

Authors: J. A. Gonzales Zamora, L. A. Espinoza

Published in: Infection | Issue 5/2017

Login to get access

Excerpt

To the Editor: …
Literature
1.
McArthur MA, Kalu SU, Foulks AR, Aly AM, Jain SK, Patel JA. Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy. Pediatr Infect Dis J. 2009;28(12):1127–9.CrossRefPubMed
2.
Chaubey SK, Sinha AK, Phillips E, Russell DB, Falhammar H. Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection. Sex Health. 2009;6(3):254–7.CrossRefPubMed
3.
Darunavir (Prezista®) product Information. Janssen Pharmaceuticals. Accessed 23 May 2017.
4.
Darunavir/Cobicistat (Prezcobix®) product monograph. Janssen Pharmaceuticals. Accessed 11 Aug 2017.
5.
Anson BD, Weaver JG, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD. Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005;365(9460):682–6.CrossRefPubMed
6.
Ogunmola OJ, Oladosu YO, Olamoyegun MA. QTc interval prolongation in HIV-negative versus HIV-positive subjects with or without antiretroviral drugs. Ann Afr Med. 2015;14(4):169–76.CrossRefPubMed
Metadata
Title
Sinus bradycardia induced by darunavir-ritonavir in a patient with acquired immunodeficiency syndrome
Authors
J. A. Gonzales Zamora
L. A. Espinoza
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 5/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1065-5

Other articles of this Issue 5/2017

Infection 5/2017 Go to the issue

Original Paper

Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?

Review

Lipid testing in infectious diseases: possible role in diagnosis and prognosis

Case Report

Streptococcus pyogenes: an unusual cause of salpingitis. Case report and review of the literature

Case Report

Peripherally inserted central catheter-related bloodstream infection caused by Kocuria marina in an elderly man

Original Paper

Measurement of piperacillin plasma concentrations in cancer patients with suspected infection

Correspondence

Bacterial growth and antibiotic resistance patterns in cirrhotic ascites
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits